Recommend Products

Special Offer

Bulk Products

New Arrivals

Hot Sales

Publication Products

New Arrivals

Chemical Structure Cat. No. Product Name CAS No.
Samrotamab Chemical Structure
BCP46317 Samrotamab 2052591-32-7
Samrotamab is a biosimilar that targets LRRC15.
Enapotamab Chemical Structure
BCP46316 Enapotamab 1912423-61-0
Enapotamab is an Anti-AXL Antibody.
Tepoditamab Chemical Structure
BCP46315 Tepoditamab 2044679-53-8
Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds CLEC12A on myeloid cells and CD3ε on cytotoxic T cells.
Mitazalimab Chemical Structure
BCP46314 Mitazalimab 2055640-86-1
Mitazalimab is an agonistic – or stimulatory – antibody that targets CD40, a receptor in the dendritic cells of the immune system, which are the cells that detect enemies such as cancer cells.
Onvatilimab Chemical Structure
BCP46313 Onvatilimab 1969313-51-6
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody.
Cetrelimab Chemical Structure
BCP46310 Cetrelimab 2050478-92-5
Cetrelimab (JNJ-63723283) is a monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor
Imaprelimab Chemical Structure
BCP46309 Imaprelimab 2014343-04-3
Imaprelimab (PRX-003) is an anti-MCAM mAb developed as a novel therapy for psoriasis
Leronlimab Chemical Structure
BCP46308 Leronlimab 674782-26-4
Leronlimab, a CCR5-specific humanised IgG4 monoclonal antibody originally developed for the treatment of HIV has been studied for the treatment of COVID-19.
Ravagalimab Chemical Structure
BCP46307 Ravagalimab 2050816-56-1
Ravagalimab is a potent CD40 antibody.
Lenvervimab Chemical Structure
BCP46306 Lenvervimab 2055006-79-4
Lenvervimab is a monoclonal anti-HBsAg antibody.
Abrezekimab Chemical Structure
BCP46305 Abrezekimab 2043952-59-4
Abrezekimab (UCB4144) is an anti-IL-13 agent that is in development as an anti-asthmatic agent.
Etigilimab Chemical Structure
BCP46304 Etigilimab 2044984-83-8
Etigilimab is a human-derived monoclonal antibody. Etigilimab targets TIGIT.
Sutimlimab Chemical Structure
BCP46303 Sutimlimab 2049079-64-1
Sutimlimab, a humanized monoclonal antibody, selectively targets the C1s protein, a C1 complex serine protease responsible for activating this pathway.
Vopratelimab Chemical Structure
BCP46302 Vopratelimab 2039148-04-2
Vopratelimab is an IgG1 ICOS antibody.
Bersanlimab Chemical Structure
BCP46301 Bersanlimab 1987854-08-9
Bersanlimab is a biosimilar that targets ICAM1.
Iscalimab Chemical Structure
BCP46300 Iscalimab 2031153-61-2
Iscalimab is a fully human, CD40 pathway blocking, nondepleting monoclonal antibody.
Cibisatamab Chemical Structure
BCP46299 Cibisatamab 1855925-27-7
Cibisatamab (CEA-TCB) is a T cell bispecific antibody.
6-Chloropurine -9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Chemical Structure
BCP46297 6-Chloropurine -9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside 135473-15-3
GSK2256294A Chemical Structure
BCP46295 GSK2256294A 1142090-23-0
GSK2256294A is a potent and selective sEH inhibitor, which is in investigation in patients with endothelial dysfunction or abnormal tissue repair, such as diabetes, wound healing or COPD. GSK2256294 exhibited potent cell-based activity, a concentration-dependent inhibition of the conversion of 14,15-EET to 14,15-DHET in human, rat and mouse whole blood in vitro, and a dose-dependent increase in the LTX/LTX diol ratio in rat plasma following oral administration.
MNK1/2-IN-5 Chemical Structure
BCP46296 MNK1/2-IN-5 1426928-20-2
MNK1/2-IN-5 is a potent and selective MNK1/2 inhibitor as a therapeutic agent.
123下一页末页共 15063 条记录 1 / 754 页